InChI=1S/C22H32O3/c1- 2- 3- 4- 5- 12- 15- 18- 21(23) 19- 16- 13- 10- 8- 6- 7- 9- 11- 14- 17- 20- 22(24) 25/h3- 4,6- 7,10- 16,19,21,23H,2,5,8- 9,17- 18,20H2,1H3,(H,24,25) /b4- 3- ,7- 6- ,13- 10- ,14- 11- ,15- 12- ,19- 16+/t21- /m1/s1 |
ZNEBXONKCYFJAF-MBRSJONVSA-N |
C(C(O)=O)C/C=C\C/C=C\C\C=C/C=C/[C@@H](C/C=C\C/C=C\CC)O |
|
Bronsted acid
A molecular entity capable of donating a hydron to an acceptor (Bronsted base).
(via oxoacid )
|
|
human xenobiotic metabolite
Any human metabolite produced by metabolism of a xenobiotic compound in humans.
(via 14-HDoHE )
metabolite
Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
(via hydroxydocosahexaenoic acid )
|
|
View more via ChEBI Ontology
(4Z,7Z,10Z,12E,14R,16Z,19Z)- 14- hydroxydocosa- 4,7,10,12,16,19- hexaenoic acid
|
(14R)-HDHA
|
ChEBI
|
(14R)- hydroxy- (4Z,7Z,10Z,12E,16Z,19Z)- docosahexaenoic acid
|
ChEBI
|
(4Z,7Z,10Z,12E,14R,16Z,19Z)- 14- hydroxydocosahexaenoic acid
|
ChEBI
|
14(R)-HDHA
|
SUBMITTER
|
14(R)-HDoHE
|
ChEBI
|
27627498
|
Reaxys Registry Number
|
Reaxys
|
19965612
|
PubMed citation
|
Europe PMC
|
25200603
|
PubMed citation
|
Europe PMC
|
|